King's CRAs working together to fight cancer

Kerrie McNally and Tiphaine Douanne

College Research Associates Kerrie McNally and Tiphaine Douanne are combining their expertise to gain new insights into the role of protein trafficking in T cells. Kerrie, based at the MRC Laboratory of Molecular Biology, and Tiphaine, of the Cambridge Institute for Medical Research, will be working together during their King's project to elucidate some of the secrets of our cells.

Kerrie studies the mechanism of protein trafficking, the highly regulated process by which proteins are delivered to the right place at the right time in the cell. Tiphaine works on “killer” T lymphocytes, the small cells of our immune system that patrol our bodies, recognising and destroying virally infected and cancerous cells.

Combining their expertise, they hope to gain new insights into the role of protein trafficking in T cell killing. This is particularly important in the development of immunotherapies focussed on harnessing the killing potential of these cells against cancer.

Similar Entries


New study co-authored by King’s CRA Dr Sarah Whiteside explores how conventional CD4+ T cells hinder cancer immunotherapies targeting Treg cells.


As a result of an extraordinary meeting of the Governing Body, Kings College has decided that the apostrophe should no longer be used in official communications.


Oisín Huhn has been awarded the Milo Keynes Prize for his PhD thesis.

Co-Founder of Owlstone, Billy Boyle, will be available to students interested in creating their own start-ups


College Research Associate Alexander Patto (KC 2012) discusses the latest developments with his start-up company WaterScope.


Gillian Griffiths and her team have discovered how T cells are able to replenish their ability to destroy cancer cells.